Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplification.
Fukumoto W, Okamura S, Tamai M, Arima J, Kawahara I, Fukuda I, Mitsuke A, Sakaguchi T, Sugita S, Matsushita R, Tatarano S, Yamada Y, Nakagawa M, Enokida H, Yoshino H.
Fukumoto W, et al. Among authors: matsushita r.
BMC Cancer. 2024 Oct 29;24(1):1333. doi: 10.1186/s12885-024-13109-5.
BMC Cancer. 2024.
PMID: 39472827
Free PMC article.